Atorvastatin shows antitumor effect in hepatocellular carcinoma development by inhibiting angiogenesis via TGF-β1/pERK signaling pathway - Deza, Z; Caimi, G R; Noelia, M; Coli, L; Ridruejo, E; Alvarez, L (Mol Carcinog, 2023)